GlassScriptPhysician profile
Jill T Snyder
NPI 1033158175
$1,480.63
in general payments reported to CMS, 2019-2025
17 companies · $533 in 2025
The $533 reported for 2025 was more than what 82% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $383 · 2020: $92.44 · 2021: $15.60 · 2022: $182 · 2023: $257 · 2024: $17.95 · 2025: $533.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $723 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $723.11 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $426.88 | 2019-2025 | Lo Loestrin Fe, Orilissa, Ubrelvy |
| Astellas Pharma US INC | $252.57 | 2019-2025 | Veozah |
| Mayne Pharma Commercial LLC | $163.84 | 2023-2025 | |
| Pfizer INC. | $127.68 | 2019-2023 | |
| Exeltis, USA INC. | $95.00 | 2022-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $70.24 | 2023-2025 | |
| Organon LLC | $67.67 | 2022-2025 | Nexplanon |
| Sumitomo Pharma America, INC. | $62.39 | 2023-2025 | Myfembree, Gemtesa |
| Sun Pharmaceutical Industries INC. | $34.28 | 2023 | Ilumya, Winlevi |
| Millicent US INC | $29.17 | 2025 | Intrarosa, Femring, Femlyv |
| Boston Scientific Corporation | $27.81 | 2023 | Spaceoar Vue System - 10ml |
| Daiichi Sankyo INC. | $24.99 | 2023 | Injectafer |
| Amgen INC. | $22.78 | 2022 | |
| Therapeuticsmd, INC. | $21.76 | 2022 | |
| Minerva Surgical, INC | $20.33 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $19.31 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jill Snyder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.